periodontitis,aphthous ulcer,herpetic ulcer. Diseases of oral cavity, salivary glands and jaws,Other viral diseases
Conditions
Interventions
Intervention 1: intervention lased group:The group one (n = 10) is treated with
660 nm, 40 mW, continuous wave, 566 mw/cm2, class 2M, for five consecutive days (twice per
day, 30 seconds each sessio
Treatment - Devices
Treatment - Drugs
intervention lased group:The group one (n = 10) is treated with
660 nm, 40 mW, continuous wave, 566 mw/cm2, class 2M, for five consecutive days (twice per
day, 30 seconds each session).
intervention group one (lased grouo):a laser tooth brush with wavelength 660nm, output power 40mw,spot size 3mm, power density
566mw/cm2,irradiation time 10 seconds energy, density5.66 J/cm2, laser t
intervention lased group:The group one (n = 10) is treated with
655 nm, 40 mW, continuous wave, 655mw/cm2, class 2M, 30 seconds . this intervention is implemented for herpetic lesion in prodromal a
in the first control group for aphthous ulcer we will use non laser red light as placebo ,two times per day for 30seconds for 5 days
inthe first control group for herpetic lesion we will use the nonlaser red light as placebo for30seconds in the primordial and vesicle stage and also for 120 seconds in the crust stage in one week
in the second control group for aphthous ulcer we will use the adcortyl in orabase ointment,4 times per day for 5 days
in thefirst control group for reduction of the gingival inflammation we will use the nonlaser red lihgt as placebo ,two times per day at the interdental papilla
in the second control group for reduction of the gingival inflammation reduction we will use the tooth brush plus tooth paste two times per day
in the second control group for herpetic lesion we will use the acyclovir ointment in the primordial and vesicle stage four times per day in oneweek
Sponsors
Deputy For Research
Eligibility
Sex/Gender
All
Age
15 Years to 149 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:up to 15 years old; fulfilment of consent form; suffer from gingivitis and periodontitis; herpetic ulcer and aphthous ulcer exclusion criteria: pregnancy; malignancy; photosensitivity; thyroid problems; mental handicap; coagulopathy; corticosteroid application; epilepsy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dental microbial plaque index. Timepoint: weekly and monthly. Method of measurement: disclosing agent and periodontal probe and observation.;Periodontal pocket index. Timepoint: monthly. Method of measurement: periodontal probe.;Gingival bleeding index. Timepoint: weekly and monthly. Method of measurement: periodontal pocket probe and observation.;Gingival index. Timepoint: monthly. Method of measurement: periodontal probe and observation.;Visual analogue scale(VAS). Timepoint: befor intervention,immediately,daily,. Method of measurement: interview and standard cheklist.;Function activity. Timepoint: daily. Method of measurement: interview and standard check list.;Ulcer recurrent activity. Timepoint: monthly. Method of measurement: interview and standard check list.;Time of cure. Timepoint: daily weekly monthly and annually. Method of measurement: interview and check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoud Shabani
Ardebil University of Medical Sciences
Outcome results
None listed